CB
ITCI

Commerce Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Commerce Bank’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,431
Closed -$321K – 1223
2025
Q1 		$321K Sell
2,431
-4,661
-66% -$581K ﹤0.01% 993
2024
Q4 		$592K Buy
7,092
+449
+7% +$36.9K ﹤0.01% 800
2024
Q3 		$486K Sell
6,643
-134
-2% -$10.1K ﹤0.01% 895
2024
Q2 		$464K Sell
6,777
-1,108
-14% -$76.8K ﹤0.01% 873
2024
Q1 		$546K Sell
7,885
-295
-4% -$20.3K ﹤0.01% 828
2023
Q4 		$586K Sell
8,180
-93
-1% -$5.35K ﹤0.01% 788
2023
Q3 		$431K Sell
8,273
-117
-1% -$6.82K ﹤0.01% 838
2023
Q2 		$531K Sell
8,390
-100
-1% -$6.23K ﹤0.01% 782
2023
Q1 		$460K Buy
8,490
+1,140
+16% +$55.1K ﹤0.01% 836
2022
Q4 		$389K Sell
7,350
-315
-4% -$15.8K ﹤0.01% 884
2022
Q3 		$356K Buy
7,665
+2,380
+45% +$124K ﹤0.01% 890
2022
Q2 		$302K Hold
5,285
– – ﹤0.01% 942
2022
Q1 		$323K Buy
+5,285
New +$274K ﹤0.01% 978

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Commerce Bank's ITCI Position: Q2 2025 in Review

Commerce Bank sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,431 shares — an estimated $321K sold.

Commerce Bank first reported a position in ITCI in Q1 2022 and held it in 13 quarters. The position peaked at $592K in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Commerce Bank reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Commerce Bank sold 2,431 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $321K.
  • Commerce Bank first reported a position in Intra-Cellular Therapies Inc. in Q1 2022 and held it in 13 quarters.
  • Commerce Bank's Intra-Cellular Therapies Inc. position peaked at $592K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Commerce Bank's 13F filing for Q2 2025, filed 7 Aug 2025.